Through this clustering study, validated in an independent cohort, three very distinct groups in adult-onset IgAV emerged with clear-cut presentations and outcomes. This approach enables a personalized evaluation to be proposed at baseline and during the follow-up.
Maisons et al. (Sun,) studied this question.